MCRB logo

Seres Therapeutics, Inc.

MCRB
Healthcare|Biotechnology|US
$1.98
-0.11 (-5.26%)
Tangible Book / Share
$2.14
Cash / Share
$1.76
Next Earnings Report
Mar 11, 2027
EPS est. -$1.11 · Revenue est. $6.4M
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Aug 13, 2026 (S-3). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Seres Therapeutics Reports Third Quarter 2026 Financial Results and Announces Plans for Advancing Development of SER-155 To Prevent Immune Checkpoint Inhibitor-Related Enterocolitis (irEC)
Nov 4, 2026 · GlobeNewsWire
Seres Therapeutics Announces Publication of SER-155 Phase 1b Results in Nature Medicine Showing Reduced Bloodstream Infections in Allogeneic Hematopoietic Cell Transplantation Recipients
Nov 3, 2026 · GlobeNewsWire
Seres Therapeutics to Present Preclinical Data for SER-428, an Investigational Live Biotherapeutic Designed to Reduce Risk of Bloodstream Infections in Critically Ill Patients, at IDWeek 2026
Oct 15, 2026 · GlobeNewsWire
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 8, 2026 · GlobeNewsWire
Seres Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference
Sep 1, 2026 · GlobeNewsWire

SEC Filings (47)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 4, 202610-QQuarterly reportDocumentIndex
Nov 4, 20268-KMaterial eventDocumentIndex
Oct 26, 20268-KMaterial eventDocumentIndex
Aug 21, 2026EFFECTDocumentIndex
Aug 13, 2026S-3Shelf registrationDocumentIndex
Aug 5, 202610-QQuarterly reportDocumentIndex
Aug 5, 20268-KMaterial eventDocumentIndex
Aug 4, 20268-KMaterial eventDocumentIndex
Aug 4, 2026424B5Offering prospectusDocumentIndex
Jul 9, 2026S-8Employee stock planDocumentIndex
Jul 8, 20268-KMaterial eventDocumentIndex
Jul 8, 20268-KMaterial eventDocumentIndex
Jun 5, 20268-KMaterial eventDocumentIndex
Jun 1, 20268-KMaterial eventDocumentIndex
May 5, 202610-QQuarterly reportDocumentIndex
May 5, 20268-KMaterial eventDocumentIndex
Apr 27, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 27, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 16, 20268-KMaterial eventDocumentIndex
Mar 12, 202610-KAnnual reportDocumentIndex
Mar 12, 20268-KMaterial eventDocumentIndex
Mar 2, 20268-KMaterial eventDocumentIndex
Nov 5, 202510-QQuarterly reportDocumentIndex
Nov 5, 20258-KMaterial eventDocumentIndex
Oct 3, 20258-KMaterial eventDocumentIndex
Aug 6, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 6, 202510-QQuarterly reportDocumentIndex
Aug 6, 20258-KMaterial eventDocumentIndex
Jun 6, 2025SC 13G/APassive 5%+ stakeDocumentIndex
May 7, 2025S-8Employee stock planDocumentIndex
May 7, 202510-QQuarterly reportDocumentIndex
May 7, 20258-KMaterial eventDocumentIndex
Apr 22, 20258-KMaterial eventDocumentIndex
Apr 14, 20258-KMaterial eventDocumentIndex
Apr 4, 2025DEFA14AProxy / shareholder voteDocumentIndex
Mar 13, 2025DEF 14AProxy / shareholder voteDocumentIndex
Mar 13, 2025S-8Employee stock planDocumentIndex
Mar 13, 202510-KAnnual reportDocumentIndex
Mar 13, 20258-KMaterial eventDocumentIndex
Mar 3, 2025PRE 14AProxy / shareholder voteDocumentIndex